Cite
HARVARD Citation
Goldenberg, R. et al. (2019). Sodium‐glucose co‐transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol. Diabetes, obesity & metabolism. 21 (10), pp. 2192-2202. [Online].